Trial intelligence / Profile preview

Benzydamine versus placebo for prevention of radiation-induced oral mucositis in head and neck cancer

ISRCTN07033239Phase 2Completed

Sponsor
Imam Hossein Hospital
Start
Jun 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of benzydamine in stomatitis, sponsored by Imam Hossein Hospital. Primary endpoint: Reduction of mucositis. Started Jun 2009; status: completed.

02

Drugs

benzydamine
03

Conditions

stomatitis

Beyond the preview

Go deeper on ISRCTN07033239.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN07033239.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call